Clinical Cases in Pharmacology Clinical Cases  ·  Endocrinology, Diabetes and Metabolism III  ·  Pituitary  ·  Central DI vs. Cerebral Salt Wasting vs. SIADH
Endocrinology, Diabetes and Metabolism III, Case EndoPituitary-0022 — Pituitary

The Same Low Sodium, Two Opposite Treatments, and a Volume Exam That Has to Break the Tie

A single patient, five days out from suprasellar tumor resection, with hyponatremia and labs that fit both cerebral salt wasting and SIADH almost equally well. The disagreement is which one she actually has, since treating one as if it were the other risks real harm.

Abbreviations, terms, and other agents mentioned in this case SIADH — syndrome of inappropriate antidiuretic hormone secretion  ·  ADH — antidiuretic hormone (vasopressin)
Presentation

I.D., a 45-year-old woman, teaches high school chemistry and has spent the past five post-operative days, by her own account, more annoyed by missing her students' midterm than by anything her surgery actually did to her. She underwent resection of a large suprasellar craniopharyngioma five days ago; today's labs show serum sodium 126 mEq/L, down from 133 yesterday, with urine sodium elevated at 68 mEq/L and urine osmolality inappropriately concentrated relative to her low serum osmolality — a biochemical picture that, taken alone, fits both of the two real diagnoses under discussion almost equally well, which is precisely the clinical problem.

Cerebral salt wasting and SIADH produce nearly identical labs — both show hyponatremia with concentrated urine and natriuresis — but they arise from opposite physiology and demand opposite treatment. SIADH involves inappropriate ADH release causing water retention with a resulting, appropriate renal sodium excretion to match the expanded volume; the correct treatment is fluid restriction. Cerebral salt wasting, thought to be driven by natriuretic peptide release from the injured brain causing primary renal sodium loss with water following passively, produces a genuinely volume-depleted patient despite lab values that can look superficially similar; the correct treatment is salt and volume repletion, the near-opposite intervention, and fluid-restricting a patient who is actually volume-depleted from cerebral salt wasting can worsen her hyponatremia and put her at real risk of hypovolemic complications. The single most reliable way to tell them apart is not any lab value in isolation but a careful clinical assessment of her actual volume status — skin turgor, mucous membranes, orthostatic vitals, and central venous pressure if available — since cerebral salt wasting patients are volume-depleted and SIADH patients are euvolemic to mildly volume-expanded, a distinction the labs alone genuinely cannot make for her.

I.D. · 45 Post-op day 5
History
Suprasellar craniopharyngioma, resected 5 days ago
Serum sodium
126 mEq/L, down from 133 yesterday
Urine sodium
68 mEq/L — elevated, natriuresis present
Urine osmolality
Inappropriately concentrated vs. serum osmolality
Orthostatic vitals
Mild postural tachycardia noted on this morning's exam
Weight trend
Down 2.1kg since post-op day 1

Fluid-restrict or salt-replete — the labs alone won't tell you which

Neurosurgeon Opening

Her labs alone don't settle this, but her exam does — postural tachycardia and a real weight decline over five days are volume-depletion findings, not what SIADH's euvolemic-to-expanded picture would produce. I'd call this cerebral salt wasting and treat with isotonic or hypertonic saline and volume repletion, not fluid restriction.

Endocrinologist Response

I agree the exam is the deciding factor here, and I'd weight it the same way you're weighting it — but I want to be explicit about why fluid restriction would be the wrong call if we're right about cerebral salt wasting, not just a less-optimal one. Restricting fluids in a genuinely volume-depleted patient worsens both her volume status and, often, her sodium, which is the specific harm this differential exists to prevent, not a theoretical concern.

Her weight decline is the single data point I'd weight most heavily of everything in front of us — SIADH patients typically hold steady or gain weight from water retention, and a real, measured decline over five days is hard to explain under that diagnosis at all.

Neurosurgeon Final

Agreed — start isotonic saline now, with a plan to reassess sodium and volume status closely over the next 24 to 48 hours rather than assuming this is settled after one exam. If her sodium doesn't respond appropriately to volume repletion the way cerebral salt wasting should, that itself would be new information worth revisiting the diagnosis over, rather than a reason to have started differently today.

Regimen selected
Isotonic Saline (0.9% NaCl)
Volume/Sodium Repletion · IV, rate guided by volume status and sodium correction targets
Selected based on volume-depletion findings (postural tachycardia, measured weight loss) supporting cerebral salt wasting over SIADH; directly opposite to the fluid-restriction approach SIADH would call for.
Fluid Restriction — Explicitly Not Started
SIADH Management · Considered, not selected
Would be the correct approach if this were SIADH, but her exam argues against that diagnosis; starting it now, if she is actually volume-depleted, risks worsening both her hyponatremia and volume status.
Serial Sodium and Volume Reassessment
Monitoring Plan · Every 6-12 hours through the next 48 hours
Confirms the diagnosis is holding as saline is given; an inappropriate sodium response to volume repletion would itself be diagnostically informative.
Where this was left

Agreed: treat as cerebral salt wasting with isotonic saline for volume and sodium repletion, based primarily on her volume-depletion exam findings — postural tachycardia and a measured 2.1kg weight decline over five days — rather than on labs that could not distinguish the two diagnoses on their own. Serial sodium and volume reassessment every 6-12 hours through the next 48 hours, with an explicit note that an inappropriate response to saline should prompt reconsideration of the diagnosis rather than simply continuing the same treatment regardless of response.

Both physicians agreed fully once the exam findings were named as the deciding evidence; neither treated the lab similarity between the two diagnoses as resolved by labs alone, which was the actual risk this case posed.

Educational content only — a composite teaching case, not a real patient encounter or a substitute for clinical guidance. About These Cases →